ReviewMycopathologia2010
Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.
Review in Mycopathologia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 67 citations in OpenAlex.
- Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Subcutaneous pseudomycetoma of the knee caused byJournal of family medicine and primary care · 2023Article
- Redisposition of acremonium-like fungi inStudies in mycology · 2023Article
- Article
- Article
- Article
- Commentary: Acremonium species - A saprophytic fungus causing keratitis.Indian journal of ophthalmology · 2022Article
- Eumycetoma of the Foot due to Fusarium solani in a Person with Diabetes Mellitus: Report of a Case and Review of Literature.Mycopathologia · 2021Review
- Article
- Skin Immune Response of Immunocompetent and Immunosuppressed C57BL/6 Mice After Experimental Subcutaneous Infection Caused byFrontiers in microbiology · 2021Article
- Identification and characterization of a marine-derived chitinolytic fungus, Acremonium sp. YS2-2.Journal of microbiology (Seoul, Korea) · 2019Article
- Characterization of Two Species ofMycobiology · 2017Article
- New Recorded Species in Three Genera of the Sordariomycetes in Korea.Mycobiology · 2017Article
- Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections.Emerging infectious diseases · 2016Article
- Phylogeny of Sarocladium (Hypocreales).Persoonia · 2015Article
- Clinical experiences in fungal keratitis caused by Acremonium.Clinical ophthalmology (Auckland, N.Z.) · 2014Article
- Acremonium kiliense: case report and review of published studies.Mycopathologia · 2013Review
- Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.Antimicrobial agents and chemotherapy · 2013Article
- Acremonium strictum: Report of a Rare Emerging Agent of Cutaneous Hyalohyphomycosis with Review of Literatures.Mycopathologia · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unusual fungal agents that exist environmentally as saprophytes can often lead to opportunistic infections. Hyalohyphomycosis is a group of fungal infections caused by fungi characterized by hyaline septate hyphae and can infect both immunocompetent as well as immunocompromised patients. Many a times it becomes difficult to distinguish a pathogenic and a contaminant fungus, because many such agents can assume clinical significance depending on circumstances. Subcutaneous and invasive fungal infection due to the emerging hyalohyphomycotic fungus, Acremonium, has drawn the attention of clinicians and microbiologists, as a potential pathogen in patients with and without underlying risk factors. Generally considered to be minimally invasive in the past, genus Acremonium has been responsible for eumycotic mycetomas and focal infections in otherwise healthy individuals. It has also been increasingly implicated in systemic fungal diseases. The management with different antifungals in various clinical situations has been very conflicting and hence needs to be carefully evaluated. This overview is an endeavor to consolidate the available clinical infections due to Acremonium and the recommendations on treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.